Pnc Financial Services Group, Inc. Esperion Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.77 - $6.67 $166 - $233	-35 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$11.34 - $21.37 $68 - $128	-6 Reduced 14.63%	35 $0
Q2 2021 Aug 06, 2021	SELL	$19.4 - $28.71 $133,181 - $197,094	-6,865 Reduced 99.41%	41 $0
Q1 2021 May 07, 2021	BUY	$25.12 - $36.89 $160,768 - $236,096	6,400 Added 1264.82%	6,906 $193,000
Q2 2020 Aug 07, 2020	SELL	$30.04 - $51.31 $44,158 - $75,425	-1,470 Reduced 74.39%	506 $25,000
Q1 2020 May 08, 2020	BUY	$27.44 - $73.84 $54,056 - $145,464	1,970 Added 32833.33%	1,976 $62,000
Q2 2018 Aug 10, 2018	BUY	$36.2 - $76.4 $217 - $458	6 New	6 $0

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $143M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.